News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2024-03-21 7:5:25 am Spruce Biosciences, Inc. (SPRB) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings BusinessWire
2024-03-16 5:59:40 am Spruce Biosciences, Inc. (NASDAQ:SPRB) Just Reported Earnings, And Analysts Cut Their Target Price Simply Wall St.
2024-03-13 2:33:15 pm Spruce Biosciences Inc (SPRB) Reports Full Year 2023 Financial Results Amid Clinical Trial Setbacks GuruFocus.com
2024-03-13 1:8:0 pm Spruce Biosciences Reports Full Year 2023 Financial Results and Provides Corporate Updates Business Wire
2024-03-13 1:1:0 pm Spruce Biosciences Announces Topline Results from CAHmelia-203 in Adult Classic CAH and CAHptain-205 in Pediatric Classic CAH Business Wire
2024-01-30 1:5:0 pm Spruce Biosciences to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference Business Wire
2024-01-22 5:0:0 am Spruce Biosciences Completes Enrollment in CAHmelia-204 Study for Adult Classic Congenital Adrenal Hyperplasia Business Wire
2024-01-05 5:0:0 am Spruce Biosciences Reports Baseline Characteristics from CAHmelia-203 and CAHmelia-204 Studies in Adult Classic CAH Business Wire
2024-01-04 5:0:0 am Spruce Biosciences Provides Clinical Program Updates and Outlook for 2024 Business Wire
   

Please consider a small donation if you think this website provides you with relevant information